Browsing: Acquisition

This is a paid press release. Contact the press release distributor directly with any inquiries.

Aug. 13, 2026 /PRNewswire/ — Diversified Data Processing & Consulting, Inc. (“DivDat”) is pleased to announce its acquisition of Meridian Integration. The acquisition expands DivDat’s ability to help healthcare providers, municipalities, utilities, and other organizations serve their customers by providing solutions to manage critical interactions with their customers

– Planned acquisition leverages existing regulatory and commercial infrastructure and leadership’s experience in Fabry therapy commercialization –

Dimerix, a clinical-stage biopharmaceutical company developing kidney disease treatments, recently announced that it had acquired DMX-652 from Mission Therapeutics. The acquisition adds a Phase II-ready acute kidney injury (AKI) programme with a differentiated mechanism, expanding Dimerix beyond its late-stage focal segmental glomerulosclerosis (FSGS) asset

Ten billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay on July 6, 2026, to acquire Crinetics Pharmaceuticals (Nasdaq: CRNX) at $85.00 per share, roughly a 101% premium to the prior close

This is a paid press release. Contact the press release distributor directly with any enquiries.

LOS ANGELES and FRESNO, Calif., July 20, 2026 /PRNewswire/ — Truelink Capital (“Truelink”), a Los Angeles-based private equity firm focused on growth and long-term value creation, announced today that it has acquired Lyons Magnus (“Lyons” or the “Company”), a leading developer and manufacturer of specialty ingredients, beverage, and nutrition solutions serving B2B customers across the…

The $10 Billion Acquisition Is Set, as Vertex Pharmaceuticals Bets on a New Blue Ocean in Rare Endocrine Diseases | NAI 500